Introduction: Despite its success, there appears to be practical issues with Faecal Calprotectin (FC) testing in Inflammatory Bowel Diseases (IBD), including sample collection, delivery and pro
Calprotectin concentrations measured by 1440 smartphone readings and 120 ELISA tests on 40 stool samples. Treatment decisions in inflammatory bowel diseases are increasingly based on longitudinal trac
Background: Fecal calprotectin (FC) can be a valuable tool to optimize health care for patients with inflammatory bowel disease (IBD). The objective of this observational study was to determine the le